+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Respiratory Disease Vaccine Global Market Report 2024 - Product Thumbnail Image

Respiratory Disease Vaccine Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Anti-infective Vaccines Market Report 2023-2033 - Product Thumbnail Image

Anti-infective Vaccines Market Report 2023-2033

  • Report
  • September 2023
  • 303 Pages
  • Global
From
From
Respiratory syncytial virus (RSV) - Pipeline Insight, 2024 - Product Thumbnail Image

Respiratory syncytial virus (RSV) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Vaccine Sales Market Report 2023-2033 - Product Thumbnail Image

Vaccine Sales Market Report 2023-2033

  • Report
  • June 2023
  • 364 Pages
  • Global
From
COVID-19 Current Therapy Global Market Report 2024 - Product Thumbnail Image

COVID-19 Current Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Global Influenza Vaccines Market and Forecasts 2024-2032 - Product Thumbnail Image

Global Influenza Vaccines Market and Forecasts 2024-2032

  • Report
  • January 2024
  • 310 Pages
  • Global
From
Vaccine Adjuvants: Global Strategic Business Report - Product Thumbnail Image

Vaccine Adjuvants: Global Strategic Business Report

  • Report
  • April 2024
  • 193 Pages
  • Global
From
Loading Indicator